the aid library

LIST OPTIONS

Filter

2670

Sort by:

Direction:

Download (863)

View PDF (1281)

Guideline: Calcium Supplementation In Pregnant Women

World Health Organization (2013)

Download (454)

View PDF (887)

Infant feeding in areas of Zika virus transmission - Summary of rapid advice guideline, 29 June 2016

World Health Organization WHO (2016) C_WHO

Download (810)

View PDF (1317)

Nepal: Leprosy Guideline 2070 (Nepali Version)
recommended

Government of Nepal Ministry of Health Department of Health Services Leprosy Control Division (2013) C1

Download (266)

View PDF (404)

INDEX-TB GUIDELINES: Evidence Summaries and Guideline Panel Decision Tables Core Group Guideline Meeting

(2016) C1

This document contains: The systematic reviews and GRADE assessments used at the Index-TB Guideline Panel in July 2015; The Evidence to Decision tables that record the Panel’s assessment and recommendations from this meeting

Download (4539)

View PDF (1338)

Health Care Waste Management Guideline
recommended

Government of Nepal,Ministry of Health and Population, Department of Health Services (2014) C1

Download (395)

View PDF (468)

Developing drinking-water quality regulations and standards: general guidance with a special focus on countries with limited resources

World Health Organization (WHO) (2018) CC

Drinking-water quality regulations and standards developed or revised in accordance with this guidance will reflect the best practices identified in the WHO Guidelines for Drinking-water Quality to most effectively protect public health. Moreover, the regulations and standards will consider local ne... more

Download (272)

View PDF (397)

Risk reduction of cognitive decline and dementia: WHO guideline

World Health Organization WHO (2019) C_WHO

The WHO Guidelines on risk reduction of cognitive decline and dementia provide evidence-based recommendations on lifestyle behaviours and interventions to delay or prevent cognitive decline and dementia. These WHO Guidelines are an important tool for health care providers as well as governments, pol... more

Download (866)

View PDF (365)

National Hygiene and Environmental Health Communication Guideline

Ministry of Health, Ethiopia (2016) C1

Advocacy ,Social Mobilization ,Behavior Change Communications

Download (448)

View PDF (693)

Guideline on Inclusive Disaster Risk Reduction: Early Warning and Accessible Broadcasting

Dion, Betty; Qureshi, Aqeel Global Alliance on Accessible Technologies and Environments (GAATES), Asia Pacific Broadcasting Union, Asia Disaster Preparedness Center (2014) C1

- Build community resilience to coastal hazards by improving capacity of inclusive disaster management systems.
- Reduce the mortality rate of persons with disabilities in situations of risk.
- Raise awareness about inclusive policies, practices and disaster risk reduction strategies that ... more

Download (1853)

View PDF (5789)

Hand hygiene in health care in the context of Filovirus disease outbreak response. Rapid advice guideline
recommended

World Health Organization (2014)

This document provides a summary of the recommendations for hand hygiene best practices to be performed by health workers providing care and/or support to patients with filovirus infection (Ebola and Marburg viruses).

Download (658)

View PDF (572)

Menstrual Hygiene Management in Ethiopia. An Inter-sectoral issue: Policy and Implementation Guideline

Ministry of Health, Ethiopia (2018) C1

Download (336)

View PDF (1364)

Guideline for the treatment of women undergoing termination of pregnancy

Dutch Association of Abortion Specialists (NGvA) (2011) C2

Download (256)

View PDF (421)

Report of the Guideline Development Group Meeting on the use of bedaquiline in the treatment of multidrug-resistant tuberculosis

World Health Organization (2017) C_WHO

A review of available evidence (2016). 28-29 June 2016; Geneva, Switzerland The END TB strategy.

Download (373)

View PDF (543)

Namibia: HIV and AIDS Mainstreaming Guideline for Sector Responses

Ministry of Health and Social Services (MOHSS) (2017) C2

Accessed November 2, 2017

Download (214)

View PDF (247)

Clinical management of COVID-19: Living guideline, 15 September 2022
recommended

World Health Organization WHO (2022) C_WHO

The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is ... more

Download (69)

View PDF (797)

A living WHO guideline on drugs for covid-19
recommended

Rochweg, B.; et al. (2021) CC

BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379 Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE... more

Download (189)

View PDF (220)

Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline
recommended

World Health Organization WHO (2022) C_WHO

This second edition of the Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline provides the most up to date technical guidance on mask use in community settings in the context of COVID-19. In this edition, new information includes updated mask re... more

Download (100)

View PDF (123)

Clinical management of COVID-19: living guideline, 13 January 2023

World Health Organisation (WHO) (2023) C_WHO

As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4). The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr... more

Download (145)

View PDF (156)

Infection prevention and control in the context of coronavirus disease (‎COVID-19)‎: a living guideline, 13 January 2023

World Health Organisation (WHO) (2023) C_WHO

The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171 countries across all six WHO Regions and was rapidly re... more

Download (245)

View PDF (329)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Nepal: Leprosy Guideline 2070 (Nepali Version) recommended

Health Care Waste Management Guideline recommended

Hand hygiene in health care in the context of Filovirus disease outbreak response. Rapid advice guideline recommended

Clinical management of COVID-19: Living guideline, 15 September 2022 recommended

A living WHO guideline on drugs for covid-19 recommended

Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline recommended